600521-基本财务实时评分详情
华海药业600521基本财务实时评分详情
更新时间:2020-11-25 00:00:01
股票代码
600521
当期评分
股票名称
华海药业
报告日期2017-12-312018-12-312019-12-312020-09-302020-09-302020-09-30
每股经营现金流(¥)0.5240.05431.32640.80320.8032
销售净利润率(%)12.46682.647911.262318.21218.212
销售毛利率(%)54.743158.601559.466362.735562.7355
净资产收益率(%)13.092.6410.1513.613.6
营业增长率(%)22.21311.85115.76121.413421.4134
净利润增长率(%)36.4825-78.367349.829963.462963.4629
每股收益(%)0.620.090.450.40.17
现金流量比率(%)19.26721.424552.247617.830313.0756
三项费用比重(%)40.282345.300137.793232.401633.4061
每股净资产(¥)4.68323.25364.24214.07334.4113
流动比率(%)1.43641.09361.56891.5491.8461
速动比率(%)0.87420.63520.90850.93071.0922
现金比率(%)24.384519.109644.815737.177237.1772
总资产利润率(%)8.31831.44795.75285.50852.1819
主营利润比重%351.39711898.6738421.1137283.6724317.2655
应收账款(万元)160,422.90189,434.97128,911.44174,194.67146,319.77
应收票据(万元)5,284.594,203.48------
预付款项(万元)7,640.925,882.294,616.115,720.006,482.92
存货(万元)159,383.52218,480.54221,702.61218,199.92204,792.56
在建工程(万元)70,491.2781,181.0092,985.29108,811.53104,714.64
应付款项(万元)38,984.3342,830.5537,652.5949,671.9937,098.52
长期借款(万元)22,216.2990,000.00117,919.32122,971.98142,394.66
未分配利润(万元)220,980.99209,159.09259,119.07290,503.92281,185.66
商誉(万元)7,090.227,090.227,090.227,090.227,090.22
流动资产(万元)419,463.27515,503.56546,265.30583,133.19555,036.23
流动负债(万元)283,508.90476,626.14335,698.93352,936.75271,640.71
华海药业600521评分结果
72.73分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006